What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
Benedetto Vitiello spends much of his time researching Psychiatry, Randomized controlled trial, Attention deficit hyperactivity disorder, Clinical psychology and El Niño.
His works in Anxiety, Depression, Major depressive disorder, Comorbidity and Mental health are all subjects of inquiry into Psychiatry.
As part of one scientific family, Benedetto Vitiello deals mainly with the area of Randomized controlled trial, narrowing it down to issues related to the Placebo, and often Adverse effect.
His work in the fields of Methylphenidate overlaps with other areas such as Multimodal treatment.
His Clinical psychology research is multidisciplinary, incorporating perspectives in Autism and Treatment and control groups.
His El Niño study integrates concerns from other disciplines, such as Developmental psychology, Psychometrics and Clinical trial.
His most cited work include:
- A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder (2605 citations)
- Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. (1302 citations)
- Risperidone in Children with Autism and Serious Behavioral Problems (1142 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Psychiatry, Clinical psychology, Randomized controlled trial, Attention deficit hyperactivity disorder and Clinical trial.
Psychiatry is frequently linked to Placebo in his study.
The various areas that Benedetto Vitiello examines in his Placebo study include Internal medicine and Adverse effect.
His studies in Clinical psychology integrate themes in fields like Rating scale, Pharmacotherapy and Anxiety.
Benedetto Vitiello combines subjects such as Parent training and Pediatrics with his study of Randomized controlled trial.
Many of his research projects under Attention deficit hyperactivity disorder are closely connected to Multimodal treatment with Multimodal treatment, tying the diverse disciplines of science together.
He most often published in these fields:
- Psychiatry (62.04%)
- Clinical psychology (26.18%)
- Randomized controlled trial (17.80%)
What were the highlights of his more recent work (between 2014-2021)?
- Psychiatry (62.04%)
- Clinical psychology (26.18%)
- Randomized controlled trial (17.80%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Psychiatry, Clinical psychology, Randomized controlled trial, Autism spectrum disorder and Autism.
His research on Psychiatry frequently links to adjacent areas such as Pediatrics.
His Clinical psychology research is multidisciplinary, incorporating elements of Obesity and Anorexia nervosa.
His Randomized controlled trial research incorporates themes from Medical prescription, Irritability and Antipsychotic.
His research in Autism spectrum disorder tackles topics such as Placebo which are related to areas like Clinical trial, Pediatric psychopharmacology, Physical therapy, QT interval and Cardiac conduction.
His Autism study combines topics in areas such as Adverse effect, Impulsivity and Anxiety.
Between 2014 and 2021, his most popular works were:
- Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: A narrative review to highlight clinical and research needs in the acute phase and the long return to normality (216 citations)
- Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. (124 citations)
- Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression (117 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Major depressive disorder
His scientific interests lie mostly in Psychiatry, Attention deficit hyperactivity disorder, Pediatrics, Young adult and Clinical psychology.
His study ties his expertise on Randomized controlled trial together with the subject of Psychiatry.
His research integrates issues of Mental health, Persistence and Cohort in his study of Attention deficit hyperactivity disorder.
His study explores the link between Pediatrics and topics such as Stimulant that cross with problems in Methylphenidate, Atomoxetine, Pharmacotherapy, Atomoxetine hydrochloride and Antipsychotic.
His studies deal with areas such as Cigarette smoking, Longitudinal study, Observational study and Substance abuse as well as Young adult.
His study in the field of Psychopathology is also linked to topics like Construct, Injury prevention and Human factors and ergonomics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
